Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Exchange Rate Effect: 2023-2024

Historic Exchange Rate Effect for SAB Biotherapeutics (SABS) over the last 2 years, with Dec 2024 value amounting to -$241,198.

  • SAB Biotherapeutics' Exchange Rate Effect fell 178.96% to -$37,537 in Q3 2025 from the same period last year, while for Sep 2025 it was -$104,384, marking a year-over-year change of. This contributed to the annual value of -$241,198 for FY2024, which is 1429.35% down from last year.
  • Latest data reveals that SAB Biotherapeutics reported Exchange Rate Effect of -$241,198 as of FY2024, which was down 1,429.35% from $18,144 recorded in FY2023.
  • SAB Biotherapeutics' 5-year Exchange Rate Effect high stood at $18,144 for FY2023, and its period low was -$241,198 during FY2024.
  • Its 2-year average for Exchange Rate Effect is -$111,527, with a median of -$111,527 in 2023.
  • Data for SAB Biotherapeutics' Exchange Rate Effect shows a maximum YoY crashed of 1,429.35% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows SAB Biotherapeutics' Exchange Rate Effect stood at $18,144 in 2023, then crashed by 1,429.35% to -$241,198 in 2024.